Inflammation-related genes in schizophrenia
Author Information
Author(s): Peter Saetre, Lina Emilsson, Elin Axelsson, Johan Kreuger, Eva Lindholm, Elena Jazin
Primary Institution: Uppsala University
Hypothesis
The main goal of this study is to find transcriptional alterations in schizophrenia that are independent of neuroleptic treatment.
Conclusion
The study found that inflammation-related pathways may be disturbed in the brains of individuals with schizophrenia.
Supporting Evidence
- Genes involved in immune response were found to be up-regulated in all groups of patients.
- Four specific genes (IFITM2, IFITM3, SERPINA3, GBP1) showed increased mRNA levels in schizophrenia.
- These genes were co-expressed in both schizophrenic subjects and controls.
- In-vitro experiments indicated that these genes are expressed in oligodendrocyte and endothelial cells.
Takeaway
This study looked at brain samples from people with schizophrenia and found that some genes related to inflammation were more active, which might help explain the disease.
Methodology
The study compared transcriptional profiles in brain autopsy samples from 55 control individuals and 55 schizophrenic subjects using microarray analysis and real-time RT-PCR.
Potential Biases
Potential confounding factors include the effects of medication and the cause of death.
Limitations
The study's findings are based on post-mortem brain samples, which may not fully represent the disease process in living patients.
Participant Demographics
The study included 110 individuals, with 55 diagnosed with schizophrenia and 55 controls, consisting of 46 females and 64 males.
Statistical Information
P-Value
0.003, 0.004, 0.004, 0.023
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website